the Dutch-GERAF Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

1075 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-25

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Geriatric patients are at high risk of cardiovascular complications, and for the development of atrial fibrillation. Often atrial fibrillation exists in these patients without specific symptoms, and could therefore remain unknown. Furthermore, concerns exist about the bleeding profile of anticoagulation in the very elderly or frail patients.

This study applies opportunistic screening for atrial fibrillation as advised in the latest ESC Guideline on the diagnosis and management of atrial fibrillation. Furthermore, multiple bleeding risk scores will be applies, to better assess the bleeding risk in very elderly or frail patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older

NCT04375241

Atrial Fibrillation

COMPLETED

SCREENING AFTER STROKE - ATRIAL FIBRILLATION

NCT06675383

Atrial Fibrillation (AF)

RECRUITING

Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden

NCT01593553

Atrial Fibrillation Stroke

UNKNOWN NA

DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation

NCT05838781

Atrial Fibrillation Atrial Flutter

COMPLETED NA

Opportunistic Screening in Pharmacies for Atrial Fibrillation in Seniors (>65 Years)

NCT03004859

Incidence of Atrial Fibrillation in Adults Aged ≥ 65

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation Frailty Major Bleed

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HeartSDK

The photoplethysmography (PPG) application enables patients to perform a finger tip heartbeat measurement and automatic analysis

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All newly referred patients of 65 years and older that visit geriatric outpatient services are eligible (including Fall clinic, Memory clinic, Pre-operative geriatric assessment clinic, or any other geriatric outpatient clinics that are led by a geriatrician).

Exclusion Criteria

* The patient has a pacemaker or implantable cardioverter defibrillator.
* The patient is known with a severe dementia, MoCA ≤ 15 points.
* The patient has a severe tremor, from whatever cause, and thus is unable to use the PPG based smartphone AF detection algorithm.

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No